Full-Time

Clinical Project Manager 2

Oncology

Updated on 6/24/2026

Syneos Health

Syneos Health

10,001+ employees

Global provider of integrated clinical-to-commercial services

Compensation Overview

$120k - $135k/yr

+ Bonus + Commission

H1B Sponsorship Available

Remote in USA

Remote

Remote within the United States.

Category
Business & Strategy (1)
Requirements
  • Bachelor's degree in a scientific, healthcare, or related field
  • 3+ years of Clinical Project Management experience supporting global oncology clinical trials
  • Experience managing studies across multiple countries and regions (North America, Europe, Asia-Pacific, Latin America, or other global regions)
  • Vendor management experience
  • Strong understanding of clinical trial operations and study lifecycle management
  • Experience supporting Phase I, Phase II, Phase III, and/or Phase IV oncology studies
  • Strong working knowledge of ICH-GCP guidelines and clinical research regulations
  • Proficiency with Microsoft Office Suite
  • Ability to work effectively within global, cross-functional matrix organizations
  • Solid Tumors: Non-Small Cell Lung Cancer (NSCLC); Small Cell Lung Cancer (SCLC); Breast Cancer; Ovarian Cancer; Cervical Cancer; Endometrial Cancer; Prostate Cancer; Colorectal Cancer; Pancreatic Cancer; Gastric Cancer; Esophageal Cancer; Hepatocellular Carcinoma (HCC); Melanoma; Renal Cell Carcinoma (RCC); Bladder Cancer; Head and Neck Cancer; Thyroid Cancer; Sarcoma; Gynecologic Malignancies
  • Hematologic Malignancies: Multiple Myeloma; Acute Myeloid Leukemia (AML); Acute Lymphoblastic Leukemia (ALL); Chronic Lymphocytic Leukemia (CLL); Chronic Myeloid Leukemia (CML); Hodgkin Lymphoma; Non-Hodgkin Lymphoma; Myelodysplastic Syndromes (MDS); Myeloproliferative Neoplasms (MPN)
  • Advanced Therapeutic Areas: Immuno-Oncology; Cell and Gene Therapy; CAR-T Programs; Bispecific Antibodies; Antibody Drug Conjugates (ADCs); Precision Medicine / Biomarker-Driven Studies
Responsibilities
  • Support and partner with Clinical Study Leads and cross-functional study teams on global oncology trials
  • Lead day-to-day study management activities across study startup, conduct, maintenance, and closeout
  • Manage study timelines, deliverables, risks, and issue resolution
  • Oversee external vendors, CROs, central laboratories, imaging vendors, and specialty providers
  • Coordinate Clinical Trial Team (CTT) meetings and drive action item follow-up
  • Support study-level planning, forecasting, and operational strategy execution
  • Monitor study performance metrics and proactively identify areas requiring intervention
  • Ensure inspection readiness and compliance with applicable regulations and sponsor requirements
  • Collaborate with stakeholders across Clinical Operations, Data Management, Biostatistics, Medical Monitoring, Regulatory Affairs, Safety, Supply Chain, and Quality
  • Contribute to study status reporting and executive-level communications
  • Support achievement of study milestones, enrollment targets, database locks, and study closeout activities
Desired Qualifications
  • Experience independently leading global oncology studies
  • Experience supporting complex, multi-regional Phase II and Phase III programs
  • Experience with early-phase oncology studies (Phase I/Ib)
  • Experience with immuno-oncology, targeted therapies, cell therapy, or hematologic malignancies
  • Familiarity with CTMS, eTMF, IRT/RTSM, and clinical data review platforms
  • Experience working in sponsor-dedicated or FSP environments

Syneos Health provides end-to-end biopharmaceutical solutions across the clinical-to-commercial spectrum. It helps biopharma companies, healthcare organizations, and investors by offering specialized expertise, insights, and technology-enabled services to move therapies faster to patients. Its offerings include Kinetic, a modern omnichannel customer engagement platform that uses targeting and analytics to coordinate nationwide healthcare communications, and Syneos One, an asset development approach that aligns strategy and execution from early concept through commercialization. The company uses AI and advanced tech to improve performance and reduce risk in drug development and market delivery. Its goal is to be a trusted partner that accelerates therapy development and delivery by combining scientific know-how with integrated, data-driven services.

Company Size

10,001+

Company Stage

IPO

Headquarters

Morrisville, North Carolina

Founded

1985

Your Connections

People at Syneos Health who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Pharma spends 30-50% of revenue on field teams, creating optimization demand.
  • AI-driven commercial analytics can improve launch performance and deepen client lock-in.
  • Global partnerships and acquisitions expand Syneos' reach across diagnostics, China, and Malaysia.

What critics are saying

  • AI conversation intelligence faces privacy and rep-consent objections, slowing enterprise rollout.
  • Domestic CROs in China undercut Bestudy-linked margins and crowd out foreign-backed vendors.
  • HelioLiver adoption risk remains high if physicians ignore reimbursement and field education efforts.

What makes Syneos Health unique

  • Syneos spans preclinical development through full commercialization and marketing capabilities.
  • KAI integration strengthens field execution with conversation intelligence and next-best-action coaching.
  • HelioLiver launch experience showcases specialty-diagnostic education across hepatology and gastroenterology networks.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Employee Stock Purchase Plan

Flexible Work Hours

Paid Vacation

Paid Sick Leave

Remote Work Options

Company News

Fierce Biotech
Mar 19th, 2026
Syneos Health scoops up Chinese CRO to secure place in ‘rapidly growing market’

North Carolina-based contract research organization Syneos Health is making a play to capitalize on China’s rapidly ascendant biopharma industry. | North Carolina-based contract research organization Syneos Health is making a play to capitalize on China’s rapidly ascendant biopharma industry. Syneos has acquired Chinese CRO Bestudy to secure a foothold in the Asian nation.

PRWeek
May 7th, 2025
Imre hires Greg Voyles as chief growth officer

Voyles joins Imre from Syneos Health, where he served as VP of commercial solutions.

Healthcare Asia Magazine
Dec 2nd, 2024
Sunway Healthcare Group, Syneos Health to expand clinical trial expertise

Sunway Healthcare Group has partnered with Syneos Health to expand clinical trial capabilities across therapeutic areas in Malaysia.

BioSpace
Oct 10th, 2024
Syneos Health Appoints Costa Panagos as Chief Executive Officer

Syneos Health appoints Costa Panagos as chief executive officer.

PRWeek
Oct 7th, 2024
Syneos Health makes senior hires

Syneos has also appointed Jen Husdan as an associate director.